跳至主要内容
临床试验/ISRCTN18107202
ISRCTN18107202已完成不适用

Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South Africa

World Health Organization (WHO) (Switzerland)0 个研究点目标入组 800 人开始时间: 2007年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy infants (birth weight greater than or equal to 2.5 kg and Apgar score greater than or equal to 9 at 5 minutes) born at study sites
  • 2. Residing less than or equal to 50 km from study sites
  • 3. Family is not planning on travel during the study period (birth to 1 month)

排除标准

  • 1. High risk newborns
  • 2. Other newborns requiring hospitalisation
  • 3. Birthweight less than 2.5 kg
  • 4. Apgar score less than 9 at 5 minutes
  • 5. Infants residing more than 50 km from study sites
  • 6. Infants whose families are planning to be absent during one month study period
  • 7. A diagnosis or suspicion of B cell immunodeficiency in participant or immediate family
  • The study will not collect information on acquired immunodefiency disease or Human Immunodeficiency Virus (HIV) status of mother or study subject.

研究者

发起方
World Health Organization (WHO) (Switzerland)

相似试验